BioSpace News Archive

Feb. 18, 2020 14:00 UTC CHICAGO--( BUSINESS WIRE )-- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that Paul R. Edick, Chairman and Chief Executive Officer of Xeris Pharmaceuticals, will participate in a fireside chat at the 9th Annual SVB Leerink Global Healthcare Conference. Date: Tuesday, February 2

Feb. 18, 2020 14:25 UTC Five Prime Therapeutics Provides Update on Phase 2 Trial of Cabiralizumab Combined with Opdivo ® in Pancreatic Cancer Phase 2 Trial of Cabiralizumab plus Opdivo (nivolumab) with and without Chemotherapy in Advanced Pancreatic Cancer Did not Meet Primary Endpoint SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )-- Five Prime Therapeutics , Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on developing immune modulators and precision

Janssen strengthens collaboration with Biomedical Advanced Research and Development Authority (BARDA) in an effort to stem the threat of the global COVID-19 outbreak

Georgia Health Information Network, the state-designated health information exchange for Georgia, has launched a new service that allows healthcare providers to share a copy of their patients’ lab results via a secure, searchable GaHIN repository.

ScopioVet with End-to-End Diagnosis Tool - Already Installed in Dozens of Veterinary Clinics - Set for Commercial Deployments in Q1

Feb. 18, 2020 14:37 UTC LIVERMORE, Calif.--( BUSINESS WIRE )-- S2 Genomics, a manufacturer and provider of automated tissue sample preparation systems, and the RIKEN Center for Integrative Medical Sciences (IMS), a leading genomics research institute, today announced that RIKEN IMS has joined the S2 Genomics Early Technology Access Program to evaluate and further develop single cell sequencing applications on the S2 Genomics Singulator™ tissue preparation system. Achieving hi

Alpha Medical, the company rebuilding women’s healthcare, announced the expansion of its mental healthcare and telepsychiatry capabilities.

Spero Health has announced that it has received its CARF International accreditation for a period of three years for its outpatient treatment of alcohol and other drugs/addiction program.

Results captured in A Mandate for Action, a report revealing a major health crisis and the astronomical effects of arthritis in the areas of pain, overall health and wellness and quality of care

Immunogenic Cell Death (ICD) Effects of PT-112 Confirmed via in vitro and in vivo Experiments Anti-Cancer Immunity Observed Across Vaccination, Abscopal and Tumor Allograft Models